about
DNA gyrase, topoisomerase IV, and the 4-quinolonesAnalysis of macromolecular biosynthesis to define the quinolone-induced postantibiotic effect in Escherichia coliThe fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitroFluoroquinolone action in mycobacteria: similarity with effects in Escherichia coli and detection by cell lysate viscosityDNA topoisomerase targets of the fluoroquinolones: a strategy for avoiding bacterial resistance.Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections.DNA gyrase: structure and function.Ofloxacin: its pharmacology, pharmacokinetics, and potential for clinical application.Effect of aerobic and anaerobic environments on antistaphylococcal activities of five fluoroquinolonesEx vivo antibacterial properties of rufloxacin compared with those of norfloxacin in a study with healthy volunteers.Mutants of Escherichia coli K-12 exhibiting reduced killing by both quinolone and beta-lactam antimicrobial agentsIsolation and characterization of an Escherichia coli strain exhibiting partial tolerance to quinolonesIn vitro activity and mechanism of action of A21978C1, a novel cyclic lipopeptide antibioticEvaluation of the efficacy of ciprofloxacin against Streptococcus pneumoniae by using a mouse protection model.Antibiotic efficacy is linked to bacterial cellular respiration.Development of Persister-FACSeq: a method to massively parallelize quantification of persister physiology and its heterogeneity.Eagle Effect in Nonreplicating Persister MycobacteriaThe mode of action of quinolones: the paradox in activity of low and high concentrations and activity in the anaerobic environment.Lytic effect of two fluoroquinolones, ofloxacin and pefloxacin, on Escherichia coli W7 and its consequences on peptidoglycan composition.Quinolone-mediated bacterial death.Biology of bacterial deoxyribonucleic acid topoisomerases.Functional relationship between bacterial cell density and the efficacy of antibiotics.Quinolones: action and resistance updated.A review of the antimicrobial activity of the fluoroquinolones.The Eagle-like effect of echinocandins: what's in a name?Insight into synergetic mechanisms of tetracycline and the selective serotonin reuptake inhibitor, sertraline, in a tetracycline-resistant strain of Escherichia coli.In vitro biological evaluation of novel broad-spectrum isothiazolone inhibitors of bacterial type II topoisomerases.Fluorinated quinolones. A review of their mode of action, antimicrobial activity, pharmacokinetics and clinical efficacy.Antibacterial action of ciprofloxacin.Comparison of recalcitrance to ciprofloxacin and levofloxacin exhibited by Pseudomonas aeruginosa bofilms displaying rapid-transport characteristics.Correlation of quinolone MIC and inhibition of DNA, RNA, and protein synthesis and induction of the SOS response in Escherichia coli.Paradoxical antibacterial activities of beta-lactams against Proteus vulgaris: mechanism of the paradoxical effect.Mechanism of action and in vitro and in vivo activities of S-6123, a new oxazolidinone compoundIn vitro activities of the quinolone antimicrobial agents A-56619 and A-56620.The fractional maximal effect method: a new way to characterize the effect of antibiotic combinations and other nonlinear pharmacodynamic interactions.Nalidixic acid-induced protein alterations in Escherichia coli.Bactericidal activity of cephalosporins in an in vitro model simulating serum levels.Non-Monotonic Survival of Staphylococcus aureus with Respect to Ciprofloxacin Concentration Arises from Prophage-Dependent Killing of Persisters.Bactericidal activity of ACH-702 against nondividing and biofilm Staphylococci.Effect of anaerobic growth on quinolone lethality with Escherichia coli.
P2860
Q24643546-36F184CD-092F-42D4-8C06-BB54BA7BA99DQ24644419-0302BFE2-3A4A-47A2-86D5-272D17425EFCQ24670241-8CEC9304-A646-4387-A6AA-37DF17195637Q28379135-B16370C4-A8B5-494D-A83E-52CF3C2EFE8CQ33740527-0D2C7B73-4267-42F5-90F0-DCECE8B2E25AQ34303042-471660BA-DF9B-403D-91A9-4A0FD747AE6FQ34507230-28804822-B5D8-4E95-A2B8-CD16C7720FEAQ34687048-37942604-F4C9-491F-8335-BDA955F2B247Q35111853-B2C5631B-625B-40F3-BBCA-BE4ABD7D9D3CQ35121357-7A2F1796-AF11-43CB-901A-756884AACDC3Q35277130-B9FF594E-242C-4DFF-AB82-DA6F1581C8A0Q35332818-A27ED5AA-86AC-4440-996E-FB52F660334CQ35570582-C4C2680D-2A97-48E9-A335-6F00E058E837Q35808500-DCEF4922-0EA7-48C3-884A-143B3B59003EQ35845962-03F4C332-49A6-4CFD-96AD-BBFB015FFFC5Q36007873-5984E73E-29DA-4512-8E98-84226CFE9397Q36290556-D0F5339D-E713-4966-922A-2FE7A24C500AQ36670132-721CF132-863D-45AA-817E-4339B832744AQ36754157-AC481B7E-9154-4EF9-82EA-8463469FE46BQ36921143-47307143-9039-4798-9363-2FA9465576FDQ37066515-18FAE9AB-0FC9-4479-B2C7-C3D5F8C6B27DQ37124158-3759DF14-D819-4752-BECA-25818DDA8928Q37595559-599E110B-E8EA-48E4-B21E-03CDBF2B925AQ37834318-C616B03D-380B-4DFC-8D7B-B96110464EA3Q38153458-856462EF-1853-47A3-BA98-BBD1856539CFQ38683231-D0ABDA02-38BC-4C5A-AD9D-0486A6B5064EQ38761164-F826EB1E-9A30-4CB9-BAF3-173AE8D47E19Q39730719-34034113-E2F0-406B-843A-F4FE1007EDC7Q39781023-22566E7C-B9F8-4471-8E05-1351A5F0B3BCQ39784372-599A3782-7954-47CF-B0D1-A7AF33D87C50Q39817311-A55FA5DC-F47C-4DE3-9C6B-0CF2F2A61FB0Q39818534-7BD45769-5D9E-4CBE-856E-5469C667A32EQ39832267-446E1928-986F-4D3F-A108-AFCF1A9F3A50Q39850428-D5D91E39-787F-455C-9A3B-E3F04984C443Q39865219-56094233-083B-4B58-A1C0-BF112F2A389EQ40616658-F4D089AA-CF94-4ECE-8DA9-42D85BC8254BQ40618786-B10CFA83-3205-4D7F-8477-5D7EEFE8127FQ40900218-142D8C1D-78CA-42B0-9BAB-57A4A4066D8DQ42231593-C021C50B-0355-4274-90B0-1475954893A1Q42602124-488FF059-C597-4091-A42B-E1ED0030213E
P2860
description
1975 nî lūn-bûn
@nan
1975年の論文
@ja
1975年論文
@yue
1975年論文
@zh-hant
1975年論文
@zh-hk
1975年論文
@zh-mo
1975年論文
@zh-tw
1975年论文
@wuu
1975年论文
@zh
1975年论文
@zh-cn
name
Nalidixic acid: an antibacterial paradox.
@en
type
label
Nalidixic acid: an antibacterial paradox.
@en
prefLabel
Nalidixic acid: an antibacterial paradox.
@en
P2860
P356
P1476
Nalidixic acid: an antibacterial paradox.
@en
P2093
P2860
P304
P356
10.1128/AAC.8.3.251
P407
P577
1975-09-01T00:00:00Z